Abstract:Introduction/Background: Deep neural networks have shown great promise in advancing drug discovery and precision medicine. By leveraging large amounts of complex biomedical and chemical data, deep learning approaches can identify novel targets, predict drug-target and drug-drug interactions, generate new molecular structures, and assist in personalized treatment selection and development. However, fully utilizing deep learning techniques for optimization across the drug development pipeline remains an ongoing challenge. Materials and Methods: A comprehensive literature review was conducted using major bibliographic databases including PubMed, Web of Science, and Scopus. Search terms included combinations of "deep learning", "drug discovery", "precision medicine", "biomedical data", and "neural networks". Over 200 papers published between 2010-2023 related to deep learning applications in pharmacology and genomics were identified and reviewed. Results: Deep learning has been widely applied at various stages of the drug discovery process including target identification/prioritization, lead generation/optimization, and prediction of molecular properties. Convolutional neural networks are commonly used for the representation and classification of biological sequence and image data for tasks such as gene expression analysis and pathogen detection from microscopy images. Graph neural networks effectively model compound structures and interactome networks to predict molecular bindings and disease associations. Multi-modal neural networks integrate diverse data types for personalized treatment response prediction and biomarker discovery. Challenges remain around data and model interpretation, generalization to new targets/diseases, and integration across domains. Discussion: While deep learning has shown promise, rigorous benchmarking and validation on real-world clinical endpoints are still needed to establish usefulness in decision-making. Data and model transparency must be improved to enable scientific insights. Privacy and security risks accompanying "real world" biomedical big data will require ethical practices. Standardization and sharing of resources/protocols could accelerate progress by enabling comparison of techniques. Combining deep learning with other AI paradigms like causal inference may further improve utility in drug discovery and precision healthcare. Conclusion: Deep neural networks demonstrate potential for optimizing drug development and precision medicine applications. Continued advancement relies on addressing challenges around data, models, validation, and ethics. Multi-disciplinary collaborations integrating machine learning, molecular biology, medicine, and other domains are needed to fully realize benefits to patients.

Few-shot meta-learning applied to whole brain activity maps improves systems neuropharmacology and drug discovery

High-throughput brain activity mapping and machine learning as a foundation for systems neuropharmacology

Meta Learning With Graph Attention Networks for Low-Data Drug Discovery

Data-Efficient Brain Connectome Analysis via Multi-Task Meta-Learning

Multi-perspective Neural Network for Dual Drug Repurposing in Alzheimer’s Disease

Meta-MolNet: A Cross-Domain Benchmark for Few Examples Drug Discovery

CNSMolGen: a bidirectional recurrent neural networks based generative model for de novo central nervous system drug design

AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders

Meta-Learning Initializations for Low-Resource Drug Discovery

Low Data Drug Discovery with One-Shot Learning

Meta-Learning for EEG Motor Imagery Classification

Brain-Inspired Meta-Learning for Few-Shot Bearing Fault Diagnosis

Evaluating deep neural networks in optimizing drug discovery and precision medicine: A review

Drug repositioning for Alzheimer's disease with transfer learning

Virtual Screening of Molecules via Neural Fingerprint-based Deep Learning Technique

Prior-Knowledge and Attention-based Meta-Learning for Few-Shot Learning

A few-shot link prediction framework to drug repurposing using multi-level attention network

Automated Design and Optimization of Multitarget Schizophrenia Drug Candidates by Deep Learning

A spatial hierarchical network learning framework for drug repositioning allowing interpretation from macro to micro scale

Rapid Progress in Neuroimaging Technologies Fuels Central Nervous System Translational Medicine

CNSMolGen: A Bidirectional Recurrent Neural Network-Based Generative Model for De Novo Central Nervous System Drug Design